Skip to main content

Peripheral Neuropathy and cannabis in Oregon

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
24 oz usable + 6 mature…
POSSESSION
$200/yr
STATE FEE
14–45 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Oregon statute and program

The Oregon Medical Marijuana Program (OMMP) is the operating authority for Oregon patient certification. The authoritative legal text is: Oregon Revised Statutes Chapter 475C: Cannabis Regulation. The program portal is at Oregon Medical Marijuana Program (OMMP).

What the evidence says about cannabis and Peripheral Neuropathy

Peripheral neuropathy is damage to or dysfunction of the peripheral nervous system (nerves outside the brain and spinal cord). Common causes include diabetes mellitus, chemotherapy, HIV infection, alcohol use, autoimmune disease, vitamin deficiency, infection, trauma, and inherited disorders. Symptoms typically include burning or shooting pain, tingling, numbness, weakness, and loss of coordination, most often in a stocking-glove distribution affecting feet first and then hands.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Peripheral Neuropathy page.

How to qualify in Oregon

The Oregon Medical Marijuana Program (OMMP) requires the following registration steps for a Peripheral Neuropathy patient (or any qualifying diagnosis):

  1. Get an attending-physician statement from an Oregon-licensed practitioner. Under ORS 475C.770 et seq. (Oregon Medical Marijuana Act, voters approved Measure 67 of 1998), any Oregon-licensed physician (MD or DO), nurse practitioner, naturopathic physician, or physician assistant may provide an attending-physician statement. Qualifying debilitating medical conditions include cancer, glaucoma, HIV/AIDS, MS, agitation due to Alzheimer’s, cachexia, severe pain, severe nausea, seizures, severe and persistent muscle spasms, and PTSD.
  2. Apply through the Oregon Health Authority Medical Marijuana Program portal. The patient creates an account in the Oregon Health Authority (OHA) Oregon Medical Marijuana Program (OMMP) online portal, uploads the attending-physician statement, an Oregon driver license or state ID, and a passport-style photograph. Caregivers register separately at no additional state fee.
  3. Pay the $200 state registration fee. The annual OMMP patient registration fee is $200 — among the highest in the United States. Reduced fees apply for SNAP recipients ($60), Oregon Health Plan recipients ($50), veterans receiving 100% VA disability ($20), and Supplemental Security Income recipients ($20). The high standard fee reflects the program’s opt-in nature now that adult-use is available statewide.
  4. Receive the card and purchase from an Oregon dispensary. OMMP registry identification cards are typically issued within 30 days of complete application. With the card, patients may purchase up to 24 ounces of usable cannabis at OMMP-licensed dispensaries and cultivate up to 6 mature plus 12 immature plants. Adult-use retail is legal statewide for adults 21+ under Measure 91 (2014); medical patients retain substantially higher possession (24 oz vs. 1 oz adult-use) and cultivation limits, plus exemption from the state 17% retail cannabis tax. Oregon does not honor out-of-state medical cards.
State registration fee
$200
Physician visit (typical)
$150–$300
Certification to card
14–45 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Oregon registration steps, fees, and reciprocity rules, see the Oregon cannabis-laws page.

ICD-10 code

A certifying physician documenting Peripheral Neuropathy for the Oregon medical cannabis program will typically record ICD-10 G62.9 or SNOMED-CT 42658009 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Oregon list Peripheral Neuropathy as a qualifying condition for medical cannabis?

No. Oregon's qualifying-condition list does not currently include Peripheral Neuropathy, and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Peripheral Neuropathy in Oregon have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Oregon program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a Oregon medical marijuana card for Peripheral Neuropathy?

Because Oregon does not currently list Peripheral Neuropathy as a qualifying condition, a card for Peripheral Neuropathy alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Oregon who is registered with Oregon Medical Marijuana Program (OMMP) and willing to evaluate Peripheral Neuropathy cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Oregon does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the Oregon Medical Marijuana Program (OMMP) site at https://www.oregon.gov/oha/PH/DISEASESCONDITIONS/CHRONICDISEASE/MEDICALMARIJUANAPROGRAM; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Peripheral Neuropathy?

For Peripheral Neuropathy, evidence is described as moderate (supportive controlled studies exist but the picture is mixed). The mmjnow condition page for Peripheral Neuropathy lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Peripheral Neuropathy should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Peripheral Neuropathy and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Peripheral Neuropathy; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Oregon Revised Statutes Chapter 475C: Cannabis Regulationaccessed May 16, 2026
  2. Oregon Liquor and Cannabis Commissionaccessed May 16, 2026
  3. Oregon Health Authority: Medical Marijuana Programaccessed May 16, 2026
  4. Ballot Measure 91 of 2014: Control, Regulation, and Taxation of Marijuana Act (Ballotpedia)accessed May 16, 2026
  5. NORML: Oregon Laws & Penaltiesaccessed May 16, 2026
  6. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 16, 2026

    “Substantial evidence that cannabis is an effective treatment for chronic pain in adults.”

  7. NIH NINDS: Peripheral Neuropathyaccessed May 16, 2026